TIRZEPATIDE (Mounjaro®)

Clinical Indication

Management of overweight and obesity

Comments

For managing overweight and obesity in adults in line with NICE TA1026.

March 2026: Green for eligible cohort only as per LLR weight management guide

Date of classification

January 2025

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.